Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Zami Aberman Stories

Pluristem Focuses On Therapeutic Cells Delivered Intramuscularly
2012-07-21 06:21:48

Connie K. Ho for redOrbit.com — Your Universe Online 20,000,000. This is the number of peripheral artery disease patients Pluristem Therapeutics, a placenta-based cell therapy company, is working to assist. The company recently released information regarding the effectiveness of cell therapy with intramuscular delivery. To begin, Pluristem uses stem cells from the human placenta and has created a manufacturing process that produces enough cells to treat 10,000 patients from one...